Pacer Advisors
BNTX icon

Pacer Advisors’s BioNTech BNTX Stock Holding History

Pacer Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,105
Closed -$88.8K – 2581
2024
Q2 		$88.8K Buy
1,105
+2
+0.2% +$183 ﹤0.01% 2488
2024
Q1 		$102K Sell
1,103
-28
-2% -$2.69K ﹤0.01% 2715
2023
Q4 		$119K Sell
1,131
-23
-2% -$2.32K ﹤0.01% 2490
2023
Q3 		$125K Buy
1,154
+42
+4% +$4.64K ﹤0.01% 1978
2023
Q2 		$120K Buy
1,112
+82
+8% +$9.22K ﹤0.01% 2500
2023
Q1 		$128K Buy
1,030
+21
+2% +$2.88K ﹤0.01% 1521
2022
Q4 		$152K Buy
1,009
+625
+163% +$96.2K ﹤0.01% 2403
2022
Q3 		$52K Sell
384
-127
-25% -$19.4K ﹤0.01% 1914
2022
Q2 		$76K Buy
511
+7
+1% +$1.07K ﹤0.01% 2044
2022
Q1 		$86K Sell
504
-757
-60% -$127K ﹤0.01% 2217
2021
Q4 		$325K Buy
1,261
+334
+36% +$91.5K ﹤0.01% 1765
2021
Q3 		$253K Buy
927
+589
+174% +$187K ﹤0.01% 1298
2021
Q2 		$76K Buy
+338
New +$63.7K ﹤0.01% 1362

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pacer Advisors's BNTX Position: Q3 2024 in Review

Pacer Advisors sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 1,105 shares — an estimated $88.8K sold.

Pacer Advisors first reported a position in BNTX in Q2 2021 and held it in 13 quarters. The position peaked at $325K in Q4 2021. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Pacer Advisors reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 1,105 BioNTech shares in Q3 2024, an estimated $88.8K.
  • Pacer Advisors first reported a position in BioNTech in Q2 2021 and held it in 13 quarters.
  • Pacer Advisors's BioNTech position peaked at $325K in Q4 2021.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.